Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €151.00 EUR
Change Today +2.23 / 1.50%
Volume 6.2K
AMG On Other Exchanges
Hong Kong
Sao Paulo
As of 2:26 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert A. Bradway

Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Robert A. Bradway, also known as Bob, has been the Chief Executive Officer and President of Amgen, Inc. since May 23, 2012 and May 2010 respectively. Mr. Bradway is responsible for the Amgen's global commercial operations, manufacturing operations, information technology, global government affairs and worldwide compliance and business ethics organizations. He served as the Chief Operating Officer of Amgen from May 2010 to May 23, 2012. He served as the Chief Financial ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Independent Director, Member of Audit Committee and Member of Governance & Nominating Committee
Former Director


Harvard University
Amherst College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,490,769

Stock Options*

Restricted Stock Awards$7,999,917
All Other Compensation$561,121
Exercisable Options352,505
Exercisable Options Value$21,480,177
Unexercisable Options80,995
Unexercisable Options Value$4,691,548
Total Value of Options$26,171,725
Total Number of Options433,500

Total Compensation*

Total Annual Cash Compensation$5,649,890
Total Short Term Compensation$1,490,769
Other Long Term Compensation$8,561,038
Total Calculated Compensation$13,649,807
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMG:GR €151.00 EUR +2.23


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at